FDA and HHS Implement Safe Importation Action Plan to Lower Drug Prices

FDA and HHS Implement Safe Importation Action Plan to Lower Drug Prices
In this file photo, bottles of prescription drugs: Lipitor, TriCor, Plavix, Singulair, Lexapro and Avapro are displayed at Medco Health Solutions Inc., in Willingboro, N.J., June 14, 2011. AP Photo/Matt Rourke, File
Paula Liu
Updated:

The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) announced that they have taken steps toward making safe and affordable drugs accessible to American patients.

As outlined in the Safe Importation Action Plan (pdf), there are two ways to provide Americans with safe and affordable drugs—one way relying on the Federal Food, Drug, and Cosmetic Act to allow drug importation from Canada—the imported drugs from Canada will have to abide by certain conditions to make sure that they don’t pose any risk to both the health and safety of the American public, as well as making sure that the imported drugs will be able to cut costs for the American consumers.